✦ LIBER ✦

Effects of vanadate on the expression of genes involved in fuel homeostasis in animal models of Type I and Type II diabetes

✍ Scribed by S. M. Brichard

Publisher: Springer
Year: 1995
Tongue: English
Weight: 584 KB
Volume: 153
Category: Article
ISSN: 0300-8177
DOI: 10.1007/bf01075926

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Differential effect of Type I and Type I

Differential effect of Type I and Type II diabetes on antipyrine disposition in man

✍ T. Zysset; H. Wietholtz 📂 Article 📅 1988 🏛 Springer 🌐 English ⚖ 702 KB

Effects of type-I and -II interferons on

Effects of type-I and -II interferons on 90K antigen expression in ovarian carcinoma cells

✍ Christian Marth; Andreas Dreps; Clara Natoli; Alain G. Zeimet; Thomas Lang; Mart 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 French ⚖ 642 KB

The effects of diabetes and aminoguanidi

The effects of diabetes and aminoguanidine treatment on endothelial function in a primate model of type 1 diabetes

✍ Belinda A. Brooks; Scott Heffernan; Sally Thomson; Susan V. McLennan; Stephen M. 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 137 KB 👁 2 views

The effect of intensified insulin therap

The effect of intensified insulin therapy and education on the parameters of diabetes care for type I diabetic patients in Bulgaria

✍ I. Daskalova; M. Berger; E. Chanlelau; I. Mühthauser; E. Entchev 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 55 KB

Effect of the introduction of dietary su

Effect of the introduction of dietary sucrose on metabolic control in children and adolescents with type I diabetes

✍ J. Schwingshandl; S. Rippel; M. Unterluggauer; M. Borkenstein 📂 Article 📅 1994 🏛 Springer 🌐 English ⚖ 475 KB

The effect of glucose, tolbutamide, and

The effect of glucose, tolbutamide, and arginine on C-peptide release during remission in type I diabetes mellitus

✍ U. Vetter; E. Heinze; A. Thon; W. Beischer; W. Teller 📂 Article 📅 1983 🏛 Springer 🌐 English ⚖ 506 KB

The insulin secretory capacity was examined in diabetic children at the time of partial clinical remission during which their condition could be managed with low insulin therapy (less than 0.5 U insulin/kg body weight) and no urinary glucose excretion. The extent of the residual beta cell function i